CL2011000085A1 - Procedimiento para la produccion de una composicion de glicosaminoglicano, que comprende someter a cromatografia un homogeneizado de material de un animal marino no mamifero usando una matriz cromatografica en la forma de un absorbedor de membrana. - Google Patents

Procedimiento para la produccion de una composicion de glicosaminoglicano, que comprende someter a cromatografia un homogeneizado de material de un animal marino no mamifero usando una matriz cromatografica en la forma de un absorbedor de membrana.

Info

Publication number
CL2011000085A1
CL2011000085A1 CL2011000085A CL2011000085A CL2011000085A1 CL 2011000085 A1 CL2011000085 A1 CL 2011000085A1 CL 2011000085 A CL2011000085 A CL 2011000085A CL 2011000085 A CL2011000085 A CL 2011000085A CL 2011000085 A1 CL2011000085 A1 CL 2011000085A1
Authority
CL
Chile
Prior art keywords
homogenate
production
marine animal
chromatographic matrix
membrane absorber
Prior art date
Application number
CL2011000085A
Other languages
English (en)
Inventor
Ragnar Flengsrud
Original Assignee
Hepmarin As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hepmarin As filed Critical Hepmarin As
Publication of CL2011000085A1 publication Critical patent/CL2011000085A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0066—Isolation or extraction of proteoglycans from organs
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)

Abstract

Procedimiento para la producción de una composición de glicosaminoglicano, que comprende someter a cromatografía un homogeneizado de material de un animal marino no mamífero que contiene glicosaminoglicano usando una matriz cromatográfica en la forma de un absorbedor de membrana; composición y uso de glicosaminoglicanos.
CL2011000085A 2008-07-15 2011-01-14 Procedimiento para la produccion de una composicion de glicosaminoglicano, que comprende someter a cromatografia un homogeneizado de material de un animal marino no mamifero usando una matriz cromatografica en la forma de un absorbedor de membrana. CL2011000085A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0812919.9A GB0812919D0 (en) 2008-07-15 2008-07-15 Process

Publications (1)

Publication Number Publication Date
CL2011000085A1 true CL2011000085A1 (es) 2011-07-01

Family

ID=39722304

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2011000085A CL2011000085A1 (es) 2008-07-15 2011-01-14 Procedimiento para la produccion de una composicion de glicosaminoglicano, que comprende someter a cromatografia un homogeneizado de material de un animal marino no mamifero usando una matriz cromatografica en la forma de un absorbedor de membrana.

Country Status (10)

Country Link
US (1) US20110288283A1 (es)
EP (1) EP2310421A1 (es)
JP (1) JP2011528058A (es)
CN (1) CN102124032A (es)
AU (1) AU2009272491A1 (es)
BR (1) BRPI0915926A2 (es)
CA (1) CA2730607A1 (es)
CL (1) CL2011000085A1 (es)
GB (1) GB0812919D0 (es)
WO (1) WO2010007387A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108179162A (zh) * 2018-01-16 2018-06-19 浙江海洋大学 一种低分子量肝素的制备方法
IL308411A (en) * 2021-05-12 2024-01-01 Nexeos Diagnostics Inc Methods for the production of the high molecular weight heparin (HMWH) compound

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3244214A1 (de) * 1982-11-30 1984-05-30 B. Braun Melsungen Ag, 3508 Melsungen Verfahren zur reinigung und fraktionierung von heparin
EP0337327A1 (en) * 1988-04-09 1989-10-18 Bioiberica, S.A. Process for the preparation of new oligosaccharide fractions by controlled chemical depolimerization of heparin
DE19538625C2 (de) * 1995-10-17 1999-08-12 Sartorius Gmbh Verfahren zur Abtrennung von Albumin aus Serum durch Membranionenaustauschchromatographie
DE19711083C2 (de) * 1997-03-18 1999-04-29 Sartorius Gmbh Vorrichtung und Verfahren für die adsorptive Stofftrennung mit Adsorptionsmembranen
TW422712B (en) * 1997-04-01 2001-02-21 Wako Pure Chem Ind Ltd Liquid test components separation method and equipment thereof
JP2002532383A (ja) * 1998-09-15 2002-10-02 ニゾ フード リサーチ 生物学的液体からペプチドを製造する方法及びその方法で得られるペプチド
AU2002236477A1 (en) * 2000-11-21 2002-06-03 The Texas A & M University System Fgf-affinity chromatography
WO2002076475A2 (en) * 2001-03-23 2002-10-03 Bioparken As Glycosaminoglycan anticoagulants derived from fish
RU2304463C2 (ru) * 2001-06-22 2007-08-20 Аргонид Корпорейшн Наноразмерный электроположительный волокнистый адсорбент
DE10236664B4 (de) * 2002-08-09 2016-05-12 Sartorius Stedim Biotech Gmbh Verfahren und Vorrichtung zur adsorptiven Stofftrennung
GB0229696D0 (en) * 2002-12-20 2003-01-29 Amersham Biosciences Ab Separation medium
EP1866427A4 (en) * 2005-03-30 2010-09-01 Novo Nordisk As METHOD OF MANUFACTURING PEPTIDES PRODUCED IN INSECT CELL LINES
GB0509433D0 (en) * 2005-05-09 2005-06-15 Uni For Milj Og Biovitenskap Method

Also Published As

Publication number Publication date
GB0812919D0 (en) 2008-08-20
EP2310421A1 (en) 2011-04-20
CN102124032A (zh) 2011-07-13
JP2011528058A (ja) 2011-11-10
US20110288283A1 (en) 2011-11-24
BRPI0915926A2 (pt) 2015-10-27
CA2730607A1 (en) 2010-01-21
AU2009272491A1 (en) 2010-01-21
WO2010007387A1 (en) 2010-01-21

Similar Documents

Publication Publication Date Title
HN2009000379A (es) Anticuerpo especifico prlr y sus usos
CL2011003085A1 (es) Compuestos derivados de 1-(piperidin-4-il)-pirazol, moduladores de la actividad del receptor acoplado a proteina g, gpr 119; composicion farmaceutica; uso de los compuestos en el tratamiento de la diabetes o de una morbilidad asociada con dicha diabetes.
CL2008002076A1 (es) Compuestos derivados de ariloxazoles sustituidos; procedimiento de preparacion de dichos compuestos; composicion farmaceutica que los comprende; y su uso para tratar diabetes, sindrome metabolico, dislipidemias, entre otras enfermedades.
BRPI0820497A2 (pt) Processo para produção de etanol utilizando celulose com enzimas geradas através de cultura do estado sólido.
SG149759A1 (en) Media for affinity chromatography
BRPI0915728A2 (pt) composição enzimática, processo para preparar a composição, uso da composição enzimática, e, composição detergente.
CL2008002319A1 (es) Compuestos derivados de pirrolopirimidina; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar cancer.
CL2008001656A1 (es) Anticuerpo anti-c3b; composicion farmaceutica que lo comprende, y su uso para prevenir o tratar un trastorno asociado con el complemento; kit que lo contiene.
ATE493081T1 (de) Faserverstärktes verbundmaterial
CL2012003625A1 (es) Una composicion acuosa que contiene bromhexina, en donde la composicion tiene una cantidad de azucar-alcoholes inferior a 10 g referida a 100 ml de la composicion; y su uso para la terapia secretorica en enfermedades broncopulmonares agudas y cronicas.
MX276615B (es) Proceso para preparar prepolimeros de poliuretano actinicamente curables que contienen alofanato con resistencia incrementada.
BRPI0813680A2 (pt) AGENTES DE iRNA, COMPOSIÇÃO FARMACÊUTICA COMPREENDENDO OS MESMOS, BEM COMO SEU USO.
BRPI0814420A2 (pt) composição, e, uso de álcool alcoxilado.
BRPI0814593A2 (pt) Composto, composição farmacêutica que o contém e uso do composto.
BRPI0923915A2 (pt) endoglucanases fúngicas, sua produção e uso
CL2008000873A1 (es) Compuestos derivados de pirrolidin amidas; composicion farmaceutica que comprende dichos compuestos; y su uso para tratar trombosis.
CR20110553A (es) Terapia complementaria contra el cáncer
CL2008002558A1 (es) Compuestos derivados de catecolamina sustituidas, composicion farmaceutica, util para tratar parkinson, huntington, psicosis, impotencia e insuficiencia renal, entre otras enfermedades.
CL2008002486A1 (es) Comprimido divisible de liberacion modificada que comprende glicazida, un derivado de celulosa elegido entre: hmc, hec, hpc y/o hpmc y un aglutinante elegido entre: maltodextrina, polividona o hpmc; uso para tratar diabetes.
AR074985A1 (es) Bacterias etanologenicas y su uso en la produccion de etanol
BRPI0908833A2 (pt) Composição polimérica elastomérica biodegradável, processo para preparar uma composição polimérica, e, uso da composição polimérica.
NL2003068A1 (nl) Parallel process focus compensation.
BRPI0810399A2 (pt) Composto, composição farmacêutica que o contém e uso do mesmo
ATE532814T1 (de) Neue ammonium-polyurethan- und/oder polycarbonat- verbindungen
BRPI0810560A2 (pt) Composição de bebida, processo para produzir uma composição de bebida, e, uso de uma composição de bebida.